| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |